Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2009-02-13
2010-11-16
Desai, Anand U (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S006120, C435S007210, C435S252300, C435S326000, C530S350000, C536S023100
Reexamination Certificate
active
07833972
ABSTRACT:
A method of suppressing the differentiation of an adipocite and/or lipid accumulation in an adipocyte, which comprises contacting the adipocyte with a protein comprising the amino acid sequence of SEQ ID NO: 2 or a salt thereof, or with a polynucleotide comprising a sense strand sequence encoding a protein comprising the amino acid sequence of SEQ ID NO: 2.
REFERENCES:
patent: 7189807 (2007-03-01), Goddard et al.
patent: 2002/0037540 (2002-03-01), Ali et al.
patent: 2002/0197679 (2002-12-01), Tang et al.
patent: 2003/0032155 (2003-02-01), Baker et al.
patent: 2003/0040471 (2003-02-01), Watson et al.
patent: WO 99/14328 (1999-03-01), None
patent: WO 00/53758 (2000-09-01), None
patent: WO 01/00638 (2001-01-01), None
patent: WO 01/48192 (2001-07-01), None
patent: WO 01/51636 (2001-07-01), None
patent: WO 01/57188 (2001-08-01), None
patent: WO 01/64835 (2001-09-01), None
patent: WO 02/22886 (2002-03-01), None
Greeenbaum et al. (2003) Comparing protein abundance and mRNA expression levels on a genomic scale, Genome Biol., vol. 4, isssue 9, pp. 117.1-117.8.
Dictionary (2010, updated) “represent”, Encarta.msn.com/dictionary—/represented.html, pp. 1-3.
Adachi et al., Riken functional annotation of a full-length mouse cDNA collection, Genbank, Jul. 10, 2000 Accession AK07787 & Apr. 16, 2002 Accession AK077118.
Adachi at al., Riken functional annotation of a full-length mouse cDNA collection, Genbank, Jul. 10, 2000 Accession AK09771, AK012437.
Adachi at al., Riken functional annotation of a full-length mouse cDNA collection, Genbank, Jul. 10, 2000 Accession AK17880.
Adachi at al., Riken functional annotation of a full-length mouse cDNA collection, Genbank, Jul. 16, 2001 Accession AK030584, AK0359 7 & Apr. 16, 2002 Accession AK082495, AK082963, AK080754.
Adachi at al., Riken functional annotation of a full-length mouse cDNA collection, Genbank, Jul. 16, 2001 Accession AK043006 & Apr. 16, 2002 Accession AK084668.
Arita et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,”Biochem. Biophys. Res. Common., 257(1): 79-83 (1999).
Baulande et al., “Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage,”J. Biol. Chem., 276(36): 3336-33344 (2001).
Bernlohr et al., “Fatty acid trafficking in the adipocyte,”Semin. Cell Dev. Biol., 10(1): 43-49 (1999).
Chen et al, “Discordant protein and mRNA expression in lung adenocarcinomas;”Mol. Cell. Proteomics, 1(4): 304-313 (2002).
Encarta Dictionary (2007, update), the term “represent,” http://encarta.msn.com/dictionary—/represent.html, pp. 1-2.
EPO Communication of Mar. 6, 2007, regarding Application No. 03741288.9-2401, PCT/JP0308690.
Friedman et al., “Leptin and the regulation of body weight in mammals,”Nature, 395(6704): 763-770 (1998).
Fujio et al., “Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain,”Blood, 95(7): 2204-2210 (2000).
Funahashi et al., “Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity,”Intern. Med., 38(2): 202-206 (1999).
Gombart et al., “Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias,”Blood, 99(4): 1332-1340 (2002).
Hu et al, “AdipoQ is a novel adipose-specific gene dysregulated in obesity,”J. Biol. Chem., 271(18): 10697-10703 (1996).
Kim et al., “A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation,”J. Biol. Chem., 276(14): 11252-11256 (2001).
Kishida et al., “Aquaporin adipose, a putative glycerol channel in adipocytes,”J. Biol. Chem., 275(27): 20896-20902 (2000).
Kurtzhals et al., “Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo,”Biochem. J., 312(Pt 3): 725-731 (1995).
Maeda et al., “Analysis of an expression profile of genes in the human adipose tissue,”Gene, 190(2): 227-235 (1997).
NCBI Accession No. NM—172874 (mRNA sequence) (3 pages).
NCBI Sequence Revision History for 32526860, printed Aug. 11, 2008 (1 page).
Notice of Reasons for Refusal mailed Nov. 6, 2007, for Japanese Patent Application No. 2003/194658, including translation (14 pages).
Notice of Reasons for Refusal mailed Feb. 19, 2008, for Japanese Patent Application No. 2003/194658, including translation (12 pages).
Notice of Reasons for Refusal mailed May 13, 2008, for Japanese Patent Application No. 2003/194658, including translation (6 pages).
Orlicky et al, “Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells,”J. Lipid Res., 39(6): 1152-1161 (1998).
Ross et al., “Podocan, a Novel Small Leucine-rich Repeat. Protein Expressed in the Sclerotic Glomerular Lesion of Experimental HIV-associated Nephropathy,”J. Biol. Chem., 278(35): 33248-33255 (2003).
Satoh, “TNF-α,”Endocrinology&Diabetology, 14(4): 347-352 (2002).
Scott et al., “Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2,”J. Biol. Chem., 277(40): 37693-37701 (2002).
Shi et al., “Role of intracellular calcium in human adipocyte differentiation,”Physiol. Genomics, 3(2): 75-82 (2000).
Shimizu-Hirota et al., “Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein family,”FEBS Letters, 563: 69-74 (2004).
Shimomura et al., “Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity,”Nature Medicine, 2(7): 800-803 (1996).
Strausberg et al., Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences, Genbank, May 1, 2002 Accession BC028869.
Strausberg et al., Riken Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences, Genbank, Oct. 29, 2001 Accession BC016252.
Strausberg et al., Riken Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences, Genbank, Sep. 4, 2001 Accession BC013497, Feb. 1, 2002 Accession BC022616 & Mar. 1, 2002 Accession BC024888.
Sugiyama et al., “A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro,”Biochemistry, 39(51): 15817-15825 (2000).
Tsuruga et al., “Identification of novel membrane and secreted proteins upregulated during adipocyte differentiation,”Biochem. Biophys. Res. Commun., 272(1): 293-297 (2000).
Yamauchi et al., “Cloning of adiponectin receptors that mediate antidiabetic metabolic effects,”Nature, 423(6941): 762-769 (2003), and “Corrigendum,”Nature, 431(7012): 1123 (2004).
Funahashi Tohru
Furuyama Naoki
Matsuzawa Yuji
Shimomura Iichirou
Desai Anand U
Finnegan Henderson Farabow Garrett & Dunner LLP
Liu Samuel
Takeda Pharmaceutical Company Limited
LandOfFree
Proteins and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4225364